World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
82
Citations
23111
World Ranking
16198
National Ranking
506

Kosei Hirakawa publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Kosei Hirakawa sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 885 publications — 91st percentile

91% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Kosei Hirakawa D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Kosei Hirakawa sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 82 D-Index — 21st percentile

21% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Kosei Hirakawa is affiliated with Osaka Metropolitan University in Japan and has a research focus primarily within the field of Medicine, particularly oncology-related studies. Their work spans several subfields, including Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Surgery, and Immunology.

The scientist has a notable publication record in several academic journals. Frequent publication venues include:

  • Anticancer Research
  • Research Square (Research Square)
  • BMC Cancer
  • Molecular and Clinical Oncology
  • PLoS ONE

Research topics covered by Kosei Hirakawa concentrate on cancer and immunology. The main topics of their work are:

  • Cancer Immunotherapy and Biomarkers
  • Inflammatory Biomarkers in Disease Prognosis
  • Cancer Cells and Metastasis
  • Cancer Treatment and Pharmacology
  • Breast Cancer Treatment Studies
  • Cancer, Hypoxia, and Metabolism
  • Cancer Risks and Factors

Collaborations with other researchers have frequently included the following coauthors:

  • Masaichi Ohira
  • Shinichiro Kashiwagi
  • Masatsune Shibutani
  • Yuka Asano
  • Wataru Goto

A selection of recent papers authored or coauthored by Kosei Hirakawa illustrates their interests and expertise. These include:

  • Immunological potential of tertiary lymphoid structures surrounding the primary tumor in gastric cancer (2020, International Journal of Oncology)
  • Prediction of lymph node metastasis by tumor-infiltrating lymphocytes in T1 breast cancer (2020, BMC Cancer)
  • Cancer cells with high-metastatic potential promote a glycolytic shift in activated fibroblasts (2020, PLoS ONE)
  • Abundant intratumoral fibrosis prevents lymphocyte infiltration into peritoneal metastases of colorectal cancer (2021, PLoS ONE)
  • Validation of Systemic and Local Tumour Immune Response to Eribulin Chemotherapy in the Treatment of Breast Cancer (2020, Anticancer Research)

Best Publications

  • Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival

    Steffen Walter;Toni Weinschenk;Arnulf Stenzl;Romuald Zdrojowy

  • Improvement of cancer-targeting therapy, using nanocarriers for intractable solid tumors by inhibition of TGF-β signaling

    Mitsunobu R. Kano;Younsoo Bae;Caname Iwata;Yasuyuki Morishita

  • Differential gene expression profiles of scirrhous gastric cancer cells with high metastatic potential to peritoneum or lymph nodes.

    Yoshitaka Hippo;Masakazu Yashiro;Masami Ishii;Hirokazu Taniguchi

  • A Meta-analysis of the Short- and Long-Term Results of Randomized Controlled Trials That Compared Laparoscopy-Assisted and Conventional Open Surgery for Rectal Cancer

    Hiroshi Ohtani;Yutaka Tamamori;Takashi Azuma;Yoshihiro Mori

  • The pretreatment Controlling Nutritional Status (CONUT) score is an independent prognostic factor in patients with resectable thoracic esophageal squamous cell carcinoma: results from a retrospective study

    Takahiro Toyokawa;Naoshi Kubo;Tatsuro Tamura;Katsunobu Sakurai

  • Impact of the Preoperative Controlling Nutritional Status (CONUT) Score on the Survival after Curative Surgery for Colorectal Cancer

    Yasuhito Iseki;Masatsune Shibutani;Kiyoshi Maeda;Hisashi Nagahara

  • Activation of Transforming Growth Factor Beta 1 Signaling in Gastric Cancer-associated Fibroblasts Increases Their Motility, via Expression of Rhomboid 5 Homolog 2, and Ability to Induce Invasiveness of Gastric Cancer Cells

    Takatsugu Ishimoto;Takatsugu Ishimoto;Keisuke Miyake;Tannistha Nandi;Masakazu Yashiro

  • Exosomal miRNAs from Peritoneum Lavage Fluid as Potential Prognostic Biomarkers of Peritoneal Metastasis in Gastric Cancer.

    Motohiko Tokuhisa;Yasushi Ichikawa;Nobuyoshi Kosaka;Takahiro Ochiya

  • A Meta-Analysis of Randomized Controlled Trials That Compared Laparoscopy-Assisted and Open Distal Gastrectomy for Early Gastric Cancer

    Hiroshi Ohtani;Yutaka Tamamori;Kozo Noguchi;Takashi Azuma

  • A Meta-Analysis of the Short- And Long-Term Results of Randomized Controlled Trials That Compared Laparoscopy-Assisted and Open Colectomy for Colon Cancer

    Hiroshi Ohtani;Yutaka Tamamori;Yuichi Arimoto;Yukio Nishiguchi

  • Role of the Stemness Factors Sox2, Oct3/4, and Nanog in Gastric Carcinoma

    Junko Matsuoka;Masakazu Yashiro;Katsunobu Sakurai;Naoshi Kubo

  • Somatic mutations of epidermal growth factor receptor in colorectal carcinoma

    Hisashi Nagahara;Koshi Mimori;Mitsuhiko Ohta;Tohru Utsunomiya

  • Prognostic Value of Microsatellite Instability in Resectable Pancreatic Cancer

    Bunzo Nakata;Yan Qing Wang;Masakazu Yashiro;Nobuaki Nishioka

  • Phase II study of oral S‐1 for treatment of metastatic colorectal carcinoma

    Kuniaki Shirao M.D.;Atsushi Ohtsu M.D.;Hideho Takada M.D.;Yasushi Mitachi M.D.

  • Inhibition of Cyclooxygenase-2 Suppresses Lymph Node Metastasis via Reduction of Lymphangiogenesis

    Caname Iwata;Mitsunobu R. Kano;Akiyoshi Komuro;Masako Oka

  • Foretinib (GSK1363089), a multi-kinase inhibitor of MET and VEGFRs, inhibits growth of gastric cancer cell lines by blocking inter-receptor tyrosine kinase networks.

    Yu Kataoka;Toru Mukohara;Hideo Tomioka;Yohei Funakoshi

  • HER2 overexpression correlates with survival after curative resection of pancreatic cancer

    Masahiro Komoto;Bunzo Nakata;Ryosuke Amano;Nobuya Yamada

  • Predictive Potential of Preoperative Nutritional Status in Long-Term Outcome Projections for Patients with Gastric Cancer

    Katsunobu Sakurai;Masaichi Ohira;Tatsuro Tamura;Takahiro Toyokawa

  • Meta-analysis of the results of randomized controlled trials that compared laparoscopic and open surgery for acute appendicitis.

    Hiroshi Ohtani;Yutaka Tamamori;Yuichi Arimoto;Yukio Nishiguchi

  • Usefulness of non-magnifying narrow-band imaging in screening of early esophageal squamous cell carcinoma: a prospective comparative study using propensity score matching.

    Yasuaki Nagami;Kazunari Tominaga;Hirohisa Machida;Masami Nakatani

Frequent Co-Authors

Masakazu Yashiro
Masakazu Yashiro Osaka Metropolitan University
Kohei Miyazono
Kohei Miyazono University of Tokyo
Masaaki Inaba
Masaaki Inaba Osaka Metropolitan University
Koshi Mimori
Koshi Mimori Kyushu University
Masaki Mori
Masaki Mori Kyushu University
Wataru Yasui
Wataru Yasui Hiroshima University
Norifumi Kawada
Norifumi Kawada Osaka Metropolitan University
Yasuyuki Morishita
Yasuyuki Morishita University of Tokyo
Shoji Natsugoe
Shoji Natsugoe Kagoshima University
Yusuke Nakamura
Yusuke Nakamura National Institutes of Biomedical Innovation, Health and Nutrition

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine doesn’t always require going to medical school. There are several health administration degree programs available online, providing a flexible path for those interested in the management side of healthcare. Many of these programs are designed for affordability, allowing students to balance finances and education.

For those aiming for advanced leadership roles, the cheapest mha programs online healthcare offer a strategic way to earn a Master’s in Healthcare Administration. These programs prepare graduates for executive roles in hospitals, clinics, and other healthcare organizations.

Nursing professionals looking to elevate their careers can enroll in one of the cheapest online bsn to dnp programs. A Doctor of Nursing Practice (DNP) can open doors to advanced practice, leadership, and teaching positions within the healthcare sector.

Additionally, for those interested in pharmacy, pursuing pharmacy school online accredited programs can lead to a rewarding career as a pharmacist, with many online programs offering both quality education and financial accessibility.

Best Scientists Citing Kosei Hirakawa

Trending Scientists

Recently Published Articles